We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has approved sanofi-aventis' Adacel, a new vaccine for a single booster
immunization against pertussis (whooping cough), in combination with tetanus
and diphtheria.
Clinical research conducted by The Immune Response in association with Oregon
Health & Science University has indicated that FOXP3, a specific genetic
marker on T-cells known to be involved in maintaining immune tolerance and regulation
of autoimmune diseases, is significantly reduced in patients with multiple sclerosis
(MS) compared to healthy controls.
Agennix has announced results from a randomized, placebo-controlled, NIH-sponsored,
multicenter Phase II clinical trial evaluating topical talactoferrin alfa in
diabetic neuropathic ulcers.
The FDA has accepted the Neurocrine Biosciences' new drug application (NDA)
for indiplon capsules for review for the treatment of insomnia in both adult
and elderly patients.
Trimeris and ChemBridge Research Laboratories (CRL) have signed a collaborative
agreement to discover and develop small molecule entry inhibitors of HIV.
Data show that patients with diabetes and coronary heart disease (CHD) who took
Pfizer's cholesterol-lowering medicine Lipitor and lowered their cholesterol
to well below recommended levels experienced significantly fewer heart attacks
and strokes than those who lowered their cholesterol to achieve recommended
levels.